about
Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy.P2X7 receptors mediate deleterious renal epithelial-fibroblast cross talkBlocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signalingSuramin inhibits renal fibrosis in chronic kidney disease.Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathyActivation of Sirtuin-1 Promotes Renal Fibroblast Activation and Aggravates Renal FibrogenesisGenetic or pharmacologic blockade of EGFR inhibits renal fibrosis.Autophagy protects against necrotic renal epithelial cell-induced death of renal interstitial fibroblasts.Necrotic renal epithelial cell inhibits renal interstitial fibroblast activation: role of protein tyrosine phosphatase 1BSrc inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog ExpressionInhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.Transglutaminase-1 protects renal epithelial cells from hydrogen peroxide-induced apoptosis through activation of STAT3 and AKT signaling pathways.Role of Nrf2 in chronic liver disease.The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer's disease.miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.A FGFR1 inhibitor patent review: progress since 2010.The Role of MicroRNA and LncRNA-MicroRNA Interactions in Regulating Ischemic Heart Disease.Understanding cardiomyocyte proliferation: an insight into cell cycle activity.Effects of miRNAs on myocardial apoptosis by modulating mitochondria related proteins.Efficient production of recombinant glycoprotein D of herpes simplex virus type 2 in Pichia pastoris and its protective efficacy against viral challenge in mice.MicroRNA as a Therapeutic Target in Cardiac Remodeling.LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription.Circular RNAs: A novel type of non-coding RNA and their potential implications in antiviral immunity.PIWI family emerging as a decisive factor of cell fate: An overview.Role of noncoding RNAs in regulation of cardiac cell death and cardiovascular diseases.MiR-485-5p modulates mitochondrial fission through targeting mitochondrial anchored protein ligase in cardiac hypertrophy.MEF2 signaling and human diseases.The role of miR-214 in cardiovascular diseases.Understanding the role of non-coding RNA (ncRNA) in stent restenosis.Circular RNA mediates cardiomyocyte death via miRNA-dependent upregulation of MTP18 expression.Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy.The Long Noncoding RNA D63785 Regulates Chemotherapy Sensitivity in Human Gastric Cancer by Targeting miR-422a.The circular RNA ACR attenuates myocardial ischemia/reperfusion injury by suppressing autophagy via modulation of the Pink1/ FAM65B pathwayA comprehensive review of circRNA: from purification and identification to disease marker potentialThe role of K63-linked polyubiquitination in cardiac hypertrophyCritical role of FOXO3a in carcinogenesisNoncoding RNAs as therapeutic targets in atherosclerosis with diabetes mellitusProtective role of diallyl tetrasulfide on cadmium-induced testicular damage in adult rats: A biochemical and histological studyLong Noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) Regulates Cardiomyocyte Proliferation and Cardiac Repair
P50
Q33943997-D6E1B244-7C7B-4911-BA7C-BC10446DA06BQ34501919-2950E91D-2118-403A-A4E5-8FE8EFBBCD1DQ34559028-EC2790F2-42E4-458C-864D-25BB6BE411D8Q35012404-4433775F-94BD-437F-BE88-56979208BEEEQ35188138-905B1075-B5CD-40C3-A4EF-7967E5F51C18Q35897811-B561795E-AB91-432C-BC37-E0AE4082816CQ35917468-E7E0FF7A-E5BA-49CE-96D6-DE5BBB9D1215Q36200307-C5D6A9F1-9AE0-489D-AB2E-8685A2676125Q36699821-DD61815A-E5CA-4DDE-8DE5-B4412E36C263Q36777632-3E41552D-3E96-4264-9EB5-2AEE1030CB2BQ37052016-49212BD6-CAC6-439D-81C5-7FCB08964B64Q37417291-BEB89749-D712-4E26-AABD-2B1DB7335539Q37430751-B84525DF-32E2-4AEB-9859-D1837AF15BFCQ38256342-4B34EE85-0EAA-4408-9EA8-06F3ABF9EEA7Q38658182-E4ECA26D-3A41-4DD0-AB3E-3AA1C4DC291CQ38669417-F306AB74-DCA8-4F76-BDF0-C1B1CB8C87D7Q38782612-33BA8C9C-0943-43FB-AE77-329B6E816C1DQ38956012-2880BFA1-6018-433F-94E9-90CC611B9E38Q38970421-5D9B04AF-E192-4745-872D-4A545153B784Q39051228-7D5DD4ED-9D48-42C4-B63B-8CCCBA43C225Q40443062-6270D562-87A8-4F7E-AE2D-221CA9FAEC59Q44732086-DC0DF188-8B1A-4D4B-88DB-5F1216774487Q47217934-D11DA75C-6104-4E8E-9851-6969EEA15B6AQ47304366-46C47567-34D6-4CBF-A5CE-7F7A8D4FE0CCQ47675595-36AB34D8-783A-4440-BE6B-7EA628BC473DQ47947947-8A7B5178-9CDC-4C86-A819-75DCDD3D9747Q47984483-5303D7B7-6717-4683-AA69-86ACA9E6851BQ49735398-8F42F2ED-29BE-4BE4-8A18-335365400487Q50428894-92E64AAB-2C03-45C3-AC9A-342553C19EDEQ52612814-8537888D-F1C5-4F0D-AD73-5AFB7AA89E33Q55115953-E96D44D8-53D9-47E4-A5BB-D5B538A4352CQ55469742-444CA1C6-131C-4B0C-A3B4-D2210BEE3EE2Q55619046-828BD335-4A9C-4F01-8CEF-3F52FA0E2972Q57801727-639294C0-233F-47A3-8948-8EA4922A0A72Q58706990-EB655F9F-032B-42AF-A3F2-56AF1DE69436Q58784086-8401CBB2-14A4-4C18-8A4D-224FE90346DDQ60149868-3827B1EF-7F25-4951-ACFC-E8384705041FQ60149870-87D9773D-20E5-460E-AF6C-7293E410B1F7Q60149880-AD626B34-21EA-4F08-9BDD-8AF3B4B8A147Q64374910-41DCAE7A-4281-43AF-8294-1A1DE9D1AEFF
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Murugavel Ponnusamy
@ast
Murugavel Ponnusamy
@en
Murugavel Ponnusamy
@es
Murugavel Ponnusamy
@sl
type
label
Murugavel Ponnusamy
@ast
Murugavel Ponnusamy
@en
Murugavel Ponnusamy
@es
Murugavel Ponnusamy
@sl
prefLabel
Murugavel Ponnusamy
@ast
Murugavel Ponnusamy
@en
Murugavel Ponnusamy
@es
Murugavel Ponnusamy
@sl
P106
P1153
35100730800
P31
P496
0000-0001-5558-8719